Vivani Medical (VANI) Capital Expenditures (2014 - 2026)
Vivani Medical (VANI) posted quarterly Capital Expenditures of $3000.0 for Q1 2026, down 40.0% year-over-year from $5000.0 in Q1 2025, and down 98.91% quarter-over-quarter from $274000.0 in Q4 2025.
Vivani Medical (VANI) Capital Expenditures (2014 - 2026) Analysis & Trends
Vivani Medical's Capital Expenditures history runs 13 years deep, the most recent figure standing at $3000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures fell 40.0% year-over-year to $3000.0; the TTM figure through Mar 2026 stood at $1.2 million (up 208.97% YoY), while the FY2025 annual figure was $1.2 million, up 110.97% from the prior year.
- Capital Expenditures for Q1 2026 stood at $3000.0, down from $274000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $823000.0 in Q3 2025, with the low at $3000.0 in Q1 2026.
- The 5-year median for Capital Expenditures is $71000.0 (2025), against an average of $173941.2.
- Peak annual rise in Capital Expenditures reached 1907.32% in 2025, while the deepest fall reached 97.25% in 2025.
- Vivani Medical's Capital Expenditures stood at $89000.0 in 2022, then jumped by 734.83% to $743000.0 in 2023, then sank by 60.16% to $296000.0 in 2024, then fell by 7.43% to $274000.0 in 2025, then slumped by 98.91% to $3000.0 in 2026.
- Business Quant data shows VANI's Capital Expenditures at $3000.0 in Q1 2026, $274000.0 in Q4 2025, and $823000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 251.02 Mn |
| 10 | Vivani Medical | 123.67 Mn | 103.77 Mn | - | 99,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 99,000.00 |
| Jun 30, 2026 | 99,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 274,000.00 |
| Dec 31, 2025 | 274,000.00 |
| Sep 30, 2025 | 823,000.00 |
| Sep 30, 2025 | 823,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 296,000.00 |
| Dec 31, 2024 | 296,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | 182,000.00 |
| Mar 31, 2024 | 182,000.00 |